Alumni

• Brooke R. Druliner, Ph.D., Characterizing telomere and chromatin dynamics in colorectal cell transformation (2020-2023).
• Michelle P. Lin, M.D., M.P.H., Retinal vasoreactivity is a marker for cerebral small vessel disease progression (2020-2023).
• Emmanuel M. Gabriel, M.D., Ph.D., Dynamic control of tumor vasculature to enhance systemic therapies (2019-2022).
• Gita Thanarajasingam, M.D., Tolerability of cancer immunotherapy from the patient perspective: evaluating symptomatic adverse events of checkpoint inhibitors with electronic PRO-CTCAE and toxicity over time (ToxT) analysis (2019-2022).
• Roberto A. Leon Ferre, M.D., Unveiling the immune landscape of triple-negative breast cancer molecular subtypes, with emphasis on the luminal androgen receptor subtype (2019-2022).
• Kai J. Miller, M.D., Ph.D., An implanted brain-computer interface for device control in amyotrophic lateral sclerosis (2019-2022).
• Elena Anna (Eleanna) O. De Filippis, M.D., Ph.D., Exploring the connection between adipose tissue-resident eosinophils and glucose homeostasis (2018-2021).
• Marina R. Walther-Antonio, Ph.D., Porphyromonas somerae cellular invasion and upregulation of HIF pathway in endometrial cancer (2018-2021).
• Matthew A. Warner, M.D., The impact of anemia and red blood cell transfusion on functional and quality of life outcomes in survivors of critical illness: A data scientific approach to heterogeneity in clinical responses (2018-2021).
• LaPrincess C. Brewer, M.D., M.P.H., Cardiovascular disease prevention by FAITH! (Fostering African-American improvement in Total Health): Engaging the community through mobile technology-assisted education (2017-2020).
• Mrinal S. Patnaik, M.B.B.S., Epigenetic and chromatin dysregulation in chronic myelomonocytic leukemia (2015-2019).
• Carrie A. Schinstock, M.D., Determining donor-specific antibody characteristics associated with chronic antibody-mediated rejection and early allograft loss in kidney transplant patients (2015-2019).
• Lindsay A. Renfro, Ph.D., More efficient, ethical and personalized clinical trial designs in oncology (2015-2018).
• Samar H. Ibrahim, M.B., Ch.B., Mixed-lineage kinase 3 mediates high-fat diet-induced liver injury and inflammation in nonalcoholic steatohepatitis (2014-2017).
• Kathryn J. Ruddy, M.D., Prediction of chemotherapy-related amenorrhea in breast cancer patients (2014-2017).
• Jan-Mendelt Tillema, M.D., Integrative and quantitative analysis of MRI markers in pediatric MS: Diagnostic utilization of cortical imaging markers (2014-2017).
• Nathan W. Cummins, M.D., Clinical utility of pharmacogenomic profiling to decrease antiretroviral drug discontinuation in HIV-infected patients (2013-2016).
• Carrie B. Hruska, Ph.D., Molecular breast imaging to stratify risk of mammographically dense tissue (2013-2016).
• Matthew L. Johnson, Ph.D., Linking mitochondrial bioenergetics to insulin action via oxidative stress (2014-2015).
• Ritu Banerjee, M.D., Ph.D., Population-based assessment of the clinical and molecular epidemiology of extraintestinal escherichia coli infections: Implications for design of preventive interventions (2012-2015).
• Joline E. Brandenburg, M.D., Quantitating effect of botulinum toxin on muscle in children with cerebral palsy using shearwave dispersion ultrasound vibrometry (2012-2015).
• Roxana S. Dronca, M.D., Neuroendocrine immune regulation in melanoma: Implication for novel therapeutic strategies (2012-2015).
• Emir Festic, M.D., M.S., Early administration of inhaled corticosteroids and beta agonists for the prevention of pulmonary dysfunction in patients at risk of acute lung injury (2012-2014).
• Osama A. Abulseoud, M.D., Preclinical glutamate modulation through deep brain stimulation as a novel target for alcohol addiction (2011-2014).
• Naveen L. Pereira, M.D., Pharmacogenomics of the natriuretic peptide system (2011-2014).
• Yuan Ji, Ph.D., Clinical psychopharmacogenomics: Translation of drug response biomarkers to clinical practice using high-throughput genomewide techniques (2010-2013).
• Ann Vincent, M.D., Attributes of fatigue in fibromyalgia (2010-2013).
• Ian R. Lanza, Ph.D., The impact of dietary fatty acid composition on insulin sensitivity and mitochondrial function (2009-2013).
• Abdirashid M. Shire, Ph.D., Hepatitis B and hepatitis C as risk factors for hepatocellular carcinoma in Somali immigrants — Role of viral genetics/epigenetics and the immune response (2009-2013).
• Eric W. Klee, Ph.D., Nicotine sensitization effects on the treatment of tobacco dependence (2009-2012).
• Daryl J. Kor, M.D., Risk prediction and early detection of postoperative acute lung injury (2009-2012).
• Brian Irving, Ph.D., Exercise training and individual protein synthesis rates in aging adults (2007-2012).
• Augustine S. Lee, M.D., Detection of gastric microaspiration by pepsin measurement in bronchoalveolar lavage fluid: A definitive tool for the detection of gastric aspiration as a mechanism for chronic lung diseases (2009-2011).
• Harini A. Chakkera, M.D., Predictive model for post-transplant diabetes mellitus after renal transplantation (2008-2011).
• John M. Davis III, M.D., Cytokine signatures and response to therapy in rheumatoid arthritis (2008-2011).
• Shawna L. Ehlers, Ph.D., L.P., The role of health behaviors in hematopoietic stem cell transplantation (2008-2011).
• Nilufer Ertekin-Taner, M.D., Ph.D., Alzheimer's disease risk alleles in LRRTM3/VR22 influencing disease and endophenotypes (2008-2011).
• Thomas P. Olson, Ph.D., M.S., Novel mechanisms of dyspnea in heart failure (2008-2011).
• Christopher S. Russi, D.O., The use of near infrared spectroscopy (NIRS) tissue oxygen levels in ED, ICU and EMS transport patients with undifferentiated shock (2008-2011).
• John Schmidt, Ph.D., A controlled comparison of self-regulation in orofacial pain and fibromyalgia (2008-2011).
• Jon C. Tilburt, M.D., Improving risk interpretation and communication surrounding emerging genomic technologies (2008-2011).
• Patricia J. Best, M.D., Coronary artery microvascular dysfunction: A genomic approach to the problem (2007-2011).
• Kaye M. Reid Lombardo, M.D., Inflammation-related genes as risk factors for pancreatic cancer (2007-2011).
• Jeanne M. Huddleston, M.D., M.S., Readmission as an outcome measure of health system failure in patients with congestive heart failure: A population-based study (2006-2011).
• Andrea L. Cheville, M.D., Characterization of disablement in patients with advanced lung cancer (2007-2010).
• Vitaly Herasevich, M.D., Ph.D., Syndrome surveillance in the intensive care unit: Development of customized rules (data 'sniffers') for detecting adverse events and specific time-sensitive patient problems in the ICU (2007-2010).
• Selamawit Negash, Ph.D., Successful aging in the community (2006-2010).
• Farah Ramirez Marrero, Ph.D., Cardiometabolic risk factors in HIV+ Hispanics in Puerto Rico (2006-2010).
• Sencan Unal, M.D., Proton magnetic resonance spectroscopic correlates of omega-3 fatty acid treatment in pediatric bipolar disorder (2006-2010).
• Keith A. Josephs, M.D., Predicting clinical worsening in degenerative dementias (2005-2010).
• Jasvinder A. Singh, M.D., M.P.H., Intra-articular botulinum toxin A for painful prosthetic knee joint (2006-2009).
• Jayant A. Talwalkar, M.D., Diagnostic accuracy of MR elastography for the detection of hepatic fibrosis (2006-2009).
• Karthik Ghosh, M.D., Mammographic breast density as a predictor of breast cancer: Improvement in the risk-predicting ability of the Gail model by addition of breast density, and study of histological markers of breasts density (2005-2009).
• Monica Jones, M.D., Characterization of GEP as a predictor of chemoresponse (2005-2008).